NCT03606226 - Clinical Trial References

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Citation(s)

Bize R, Johnson JA, Plotnikoff RC
Physical activity level and health-related quality of life in the general adult population: a systematic review. Prev Med. 2007 Dec;45(6):401-15. Epub 2007 Jul 21. Review.
Pedersen BK, Saltin B
Evidence for prescribing exercise as therapy in chronic disease. Scand J Med Sci Sports. 2006 Feb;16 Suppl 1:3-63. Review.
Schooling CM, Lam TH, Li ZB, Ho SY, Chan WM, Ho KS, Tham MK, Cowling BJ, Leung GM
Obesity, physical activity, and mortality in a prospective chinese elderly cohort. Arch Intern Med. 2006 Jul 24;166(14):1498-504.

FAMILY Holistic Health: Physical Activity and Dietary Attitudes and Behavioural Patterns of Chinese-speaking Individuals in the Hong Kong Community.

Clinical trial NCT03606226 - References